Your session is about to expire
← Back to Search
IV Dexamethasone for Migraine
Study Summary
This trial looks at the effectiveness of parenteral dexamethasone (a steroid) at preventing migraine recurrence in children.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I cannot take corticosteroids due to certain health conditions.I have been diagnosed with acute migraine.I did not respond to initial migraine treatment without any change in my pain level.I need strong IV medication for my severe migraine.I am currently taking corticosteroids.
- Group 1: Dexamethasone group
- Group 2: Placebo group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this investigation enrolling participants who are 55 years of age or older?
"Eligible participants are those aged between 8 and 18 years old."
What is the current participant count for this research endeavor?
"Correct. According to clinicaltrials.gov, this research endeavour -- initially posted on May 1st 2014 -- is actively recruiting participants. Specifically, 116 people are needed from a single location."
Has the Dexamethasone group been given the green light by the FDA?
"Our organisation's assessment of the Dexamethasone group yielded a score of 1 due to this being an early stage trial with scant data supporting its safety and efficacy."
Am I eligible to participate in this experiment?
"This medical trial is interested in enrolling 116 participants with migraine aged between 8 and 18. Qualifying patients have the opportunity to take part."
What conditions is the Dexamethasone cohort usually used to treat?
"Dexamethasone is frequently utilized to treat ophthalmia and sympathetic conditions. Additionally, this medication can be beneficial for patients managing eye issues such as branch retinal vein occlusion or macular edema."
Has any additional research been done concerning the effects of Dexamethasone?
"At present, 552 clinical trials are being conducted on the Dexamethasone group. Of those active studies, 144 have advanced to Phase 3. Although most of them originate in Joliet, Illinois, there's a total of 18606 locations running research for this medication."
Are there any vacancies left in this medical experiment?
"As per the information accessible on clinicaltrials.gov, this investigation is searching for suitable candidates; it was first shared on May 1st 2014 and has been revised on May 3rd 2022."
Share this study with friends
Copy Link
Messenger